NDC 72682-1904

This exact product or package identity exists in FDA auxiliary data but is not present in the current primary NDC product table. The package identity is preserved; status rows are reported source observations, not medical conclusions.

Requested NDC: 72682-1904
Product root: 72682-1904
Identity scope: Product
Primary current NDC product row: Not present

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
compounder	package	72682-1904	72682-1904-1	COMPOUNDER	Outsourcing facility compounded drug report	2026-1	2026-09-09

Compounder NDC reports#

Browse the complete compounder directory for this NDC · Browse every current compounder row in the unified auxiliary catalog · browse compounder source captures and parsed snapshots.

Establishment, FEI, Product NDC table
Establishment	FEI	Product NDC	Package NDC	Product	Active ingredients	Reporting period	Normalization
AnazaoHealth Corporation	796692619	72682-1904	72682-1904-1	Pyridoxine Hydrochloride; Magnesium Chloride; Dexpanthenol; Calcium Gluconate; Thiamine Hydrochloride; Niacinamide; Riboflavin	2.7 mg/1 mL; 10.5 mg/1 mL; 6.6 mg/1 mL; 1.3 mg/1 mL; 75 mg/1 mL; 2.6 mg/1 mL; .05 mg/1 mL	2026-1	valid